AMGN Amgen Inc

Amgen Inc. (AMGN) is currently at $239.68, down $17.99 or 6.98%

-- Would be lowest close since Aug. 24, 2020, when it closed at $235.57

-- On pace for largest percent decrease since March 12, 2020, when it fell 8.26%

-- Earlier Thursday, Amgen Inc., Cytokinetics Inc. and Laboratoires Servier SA said a pivotal phase 3 study of omecamtiv mecarbil in patients with heart failure met its primary composite endpoint but missed its secondary endpoint

-- Currently down three of the past five days

-- Down 5.7% month-to-date

-- Down 0.58% year-to-date; on pace for worst year since 2016, when it fell 9.93%

-- Down 8.15% from its all-time closing high of $260.95 on July 20, 2020

-- Up 20.64% from 52 weeks ago (Oct. 10, 2019), when it closed at $198.68

-- Down 8.15% from its 52 week closing high of $260.95 on July 20, 2020

-- Up 31.52% from its 52 week closing low of $182.24 on March 12, 2020

-- Traded as low as $239.51; lowest intraday level since Sept. 25, 2020, when it hit $237.81

-- Down 7.05% at today's intraday low; largest intraday percent decrease since March 16, 2020, when it fell as much as 9.47%

-- Worst performer in the DJIA today

-- Worst performer in the S&P 500 today

-- Worst performer in the Nasdaq 100 today

-- Subtracted 118.37 points from the DJIA so far today

All data as of 3:17:05 PM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 08, 2020 15:43 ET (19:43 GMT)

Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Apr 2023 to Apr 2024